FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used to diagnose autism spectrum disorders (ASD) in children. EEG is registered. In lead T5, the indicators of the spectral power of the alpha rhythm in the frequency band of 8-13 Hz and the total power of the delta rhythm in the frequency band of 1-4 Hz are determined. In lead C3, the index of the spectral power of the theta rhythm in the frequency band of 4-8 Hz is determined. Between leads P4 and P3 the normalized coherence of the theta rhythm in the frequency band of 4-8 Hz is determined. The indicator Υ is calculated according to the stated formula. When Υ is equal to or greater than zero, ASD is diagnosed.
EFFECT: method improves the accuracy and reliability of diagnosing ASD in children by using means of objective control and evaluation of the most significant indicators.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSTICS OF MENTAL RETARDATION LINKED TO FRAGILE X CHROMOSOME SYNDROME (FXS) IN CHILDREN AND ADOLESCENTS AGED FROM 3 TO 19 BY DATA OF SPECTRAL EEG ANALYSIS | 2021 |
|
RU2785916C2 |
| DIAGNOSTIC TECHNIQUE FOR ANXIOUS AND DEPRESSIVE DISORDERS | 2018 |
|
RU2689886C1 |
| METHOD OF DETERMINING THE NECESSITY OF USING PSYCHO PHARMACOTHERAPY AMONG THE PATIENTS WITH DISORDERS OF AUTIST SPECTRUM AT THE MOMENT OF THEIR EXAMINATION | 2017 |
|
RU2643760C1 |
| METHOD FOR DIAGNOSING CHRONIC CEREBRAL ISCHEMIA AT THE STAGE OF MODERATE COGNITIVE DISORDERS WITH ACCOMPANYING ANXIETY-DEPRESSIVE DISORDERS | 2019 |
|
RU2719667C1 |
| METHOD OF CORRECTING PSYCHOPHYSIOLOGICAL STATE OF PERSON | 2022 |
|
RU2808358C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF BEHAVIORAL REACTIONS | 2017 |
|
RU2663642C1 |
| METHOD OF DIAGNOSTICS OF SCHIZOPHRENIC DISORDER | 2017 |
|
RU2676657C1 |
| METHOD FOR DIAGNOSING A PATHOLOGICAL DESIRE FOR ALCOHOL | 2017 |
|
RU2670910C9 |
| DIAGNOSTIC TECHNIQUE FOR GENDER IDENTIFICATION DISORDER IN FEMALES | 2019 |
|
RU2705622C1 |
| METHOD FOR DIAGNOSTICS OF POSITIVE DYNAMICS OF MENTAL FUNCTIONS IN CHILDREN WITH AUTISM SPECTRUM DISORDER | 2021 |
|
RU2782121C2 |
